Aranscia
Private Company
Funding information not available
Overview
Aranscia is a precision medicine enablement company that provides a suite of diagnostic software and testing services designed for seamless integration into electronic medical records (EMRs) and clinical workflows. Founded in 2000 and headquartered in San Diego, the company operates at the intersection of oncology and immunology, offering solutions like 2bPrecise, AccessDx, Spesana, and YouScript. It targets healthcare providers with tools for pharmacogenomics, precision oncology, and population health management, positioning itself as a foundational partner for value-based care initiatives. The company is led by an experienced team with deep expertise in healthcare IT, diagnostics, and clinical operations.
Technology Platform
A common software and services architecture for integrating complex diagnostic and genomic data into clinical workflows within any EMR. The platform synthesizes data from pharmacogenetic testing, precision oncology, and other sources to deliver actionable insights at the point of care.
Opportunities
Risk Factors
Competitive Landscape
Aranscia competes in the precision medicine IT enablement space against large electronic health record (EHR) vendors like Epic and Oracle Cerner, which are building genomic modules, and against specialized software companies like Tempus, Foundation Medicine's software offerings, and standalone pharmacogenomics platforms. Its differentiation lies in its EMR-agnostic, workflow-embedded approach and its focus on being a comprehensive services partner, not just a software vendor.